UnitedHealth’s CFO Tries to ‘Wayne’ on Wall Street’s Parade After $UNH Beats and Raises Again
New phone, who dis? - UnitedHealth to 935K former Medicare members
Well, would ya look at that… the world’s least popular health insurer (read: UnitedHealth Group $UNH) beat on earnings, beat on revenue, raised full-year guidance for the third time this year, and then promptly… sent its CFO on CNBC to piss on the parade.
The deets are as follows: adjusted EPS of $4.69 vs. the $4.14 Wall Street expected, on $112.69B in revenue vs. $111.40B expected. Net income jumped ~75% to a cool $4.11B from $2.35B a year ago (spoiler: you paid for it). UNH now expects at least $20.50 in adjusted EPS for 2026, up from $19.50-$20.
Shares popped ~3% premarket, because of course they did. That makes three strong quarters in a row. Friendly reminder, this is the same stock that spent 2025 getting its cheeks clapped (CEO exit, guidance yanked, a DOJ probe into its Medicare billing).
For context, revenue actually fell from $113.16B a year ago. UNH’s turnaround plan is basically dumping grandma “exiting unprofitable contracts.” Its Medicare business has shed ~935K members since the end of 2025 as the company ditches money-losing deals in Medicare Advantage, the private Medicare plans that have been kicking insurers in the d*ck for two years (sup, Humana). The savings get yeeted at AI and “value-based care” (read: paying doctors for keeping you healthy, not for how many tests they run).
But the real reason Wall Street went all “Schwing!” was the medical cost ratio (read: the share of premiums paid out for care). It came in at 88.4% vs. the 89.9% analysts expected. Meaning, they spent less of your premium on, you know, your health.
Cue the Chief Buzzkill Officer (read: CFO Wayne DeVeydt), who told CNBC that medical costs “continue to be elevated versus historical norms” and warned the shiny new ratio shouldn’t be “misleading.” Which, fair. It’s just that “costs are elevated” is a weird thing to cry about the same day your profit jumps 75%.
Hospital stays and specialty drugs for cancer and rare diseases are still pricey af. But per Wayne, the real villain is the No Surprises Act, the law that took effect in 2022 to protect you from getting your heart ripped out (both literally and figuratively) on surprise medical bills. Its dispute process for out-of-network bills is adding at least 1 percentage point to UNH’s total medical costs, which can ultimately get passed on to you through higher premiums (surprise, surprise).
As for the good news, acute hospital admissions among members fell 15% YoY while home health admissions rose 10%. Meaning, more members are getting care on the couch instead of in a hospital bed, which is way cheaper for UNH. The company is also rolling out AI “ambient listening” tools for doctors (think: Alexa, but for your prostate exam), and patient self-scheduling ripped 27%. Wayne expects all of it to compound into 2027. Sounds legit.
All in all, if there’s one thing to take away from this, it’s this: us plebs still get the bill. Bend over, policyholders… open enrollment is coming.
Until next time, friends…

At the time of publishing, Stocks.News does not hold positions in companies mentioned in the article.